Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer

NCT00498225 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

834

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine plus TS-1
DRUG: TS-1
DRUG: Gemcitabine

Sponsor

Taiho Pharmaceutical Co., Ltd.

Collaborators

[object Object]